Pneuma is an innovative healthcare technology company specializing in the development of advanced respiratory drug delivery systems. Founded with the mission to revolutionize pulmonary care, Pneuma leverages cutting-edge digital inhaler technology to improve patient outcomes and adherence. Its flagship product integrates precision dosing with real-time data capture, enabling healthcare providers to monitor and optimize treatment for conditions such as asthma and chronic obstructive pulmonary disease (COPD).
With a growing team of dedicated engineers, scientists, and healthcare professionals, Pneuma has positioned itself as a pioneer in the intersection of medical devices and digital health. The company has garnered attention for its unique approach to combining pharmaceutical delivery with connected health solutions, and has recently secured strategic partnerships and funding to accelerate commercialization. Pneuma's work is recognized for its potential to significantly impact respiratory medicine and improve quality of life for patients worldwide.